Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1619172

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1619172

Companion Animal Diagnostics Market Size, Share, Growth Analysis, By Technology (Clinical biochemistry, Immunodiagnostics), By Animal Type (Dogs, Cats), By Application, By End User, By Region - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 165 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Companion Animal Diagnostics Market size was valued at USD 2.3 billion in 2022 and is poised to grow from USD 2.53 billion in 2023 to USD 5.34 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031).

The growing prevalence of chronic disorders in pets, coupled with advancements in diagnostics, is poised to drive significant growth in the companion animal diagnostics market. Reports indicate a staggering 40% rise in canine diabetes and a 30% increase in feline diabetes from 2012 to 2022, reflecting an urgent need for effective diagnostics. The rising number of pet owners further supports this market, with over 63.9 million households owning at least one dog and around 52 million with cats. Additionally, the demand for automated and semi-automated diagnostic testing is surging, enhancing efficiency in sample handling. Innovations such as Point of Care Diagnostics (POCD) promise expedited results, while government initiatives aimed at improving veterinary services underpin long-term market expansion. The U.S. veterinary care expenditure is expected to reach USD 33 billion by 2031.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Diagnostics Market Segmental Analysis

Global Companion Animal Diagnostics Market is segmented by Technology, Animal Type, Application, End User, and region. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecularity Molecular diagnostics, and Other Companion Animal Diagnostic Technologies. Based on Animal Type, the market is segmented into Dogs, Cats, Horses, and Other companion animals. Based on Application, the market is segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Veterinary Hospitals & Clinics, Research Institutes & Universities, and Home-care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Companion Animal Diagnostics Market

The Global Companion Animal Diagnostics market is witnessing significant growth driven by the increasing demand for rapid testing and portable diagnostic tools designed for point-of-care (PoC) services. These tools have become essential for veterinarians, facilitating the quick detection of animal illnesses, particularly in remote locations like homes or shelters, and during emergencies. Major manufacturers are focusing on developing innovative portable diagnostics that enhance workflow in veterinary hospitals and research institutions. Additionally, pet healthcare spending, including veterinary treatments and pet insurance, has surged, encouraging pet owners, especially in North America and Europe, to invest in comprehensive care for their animals. This surge in demand for efficient, cost-effective diagnostic solutions underpins the expansion of the market.

Restraints in the Global Companion Animal Diagnostics Market

The growth of the Global Companion Animal Diagnostics market may be hindered by escalating pet care expenses, particularly in developing nations where there is a shortage of veterinarians. These rising costs could deter pet owners from seeking necessary diagnostic services, ultimately impacting market expansion. Additionally, a general lack of awareness regarding animal healthcare poses a substantial challenge, preventing pet owners from recognizing the importance of regular diagnostics. Collectively, these factors will likely create significant obstacles for the companion animal diagnostics market during the projected period, impeding its potential for growth and advancement.

Market Trends of the Global Companion Animal Diagnostics Market

The Global Companion Animal Diagnostics market is witnessing a significant trend driven by heightened research and development efforts focused on the diagnostic capabilities for companion animals, especially in relation to SARS-CoV-2 exposure. As various animal species emerge as potential vectors for COVID-19, key health organizations, including the CDC and USDA, are actively engaging in monitoring and studying these vulnerabilities. This surge in research not only enhances understanding of the epidemiological impact on animal and human health but also stimulates innovation in diagnostic devices. Consequently, the market is anticipated to expand, reflecting an increased demand for advanced diagnostic solutions that ensure better health outcomes for companion animals.

Product Code: SQMIG35D2047

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies

Global Companion Animal Diagnostics Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • Clinical biochemistry
    • Clinical chemistry analysis
    • Reagents, clips, and cartridges
    • Analyzers
    • Glucose monitoring
    • Blood glucose strips
    • Glucose monitors
    • Urine glucose strips
    • Blood gas electrolyte analysis
    • Reagents, clips, and cartridges
    • Blood gas & electrolyte analyzers
  • Immunodiagnostics
    • Lateral flow assays
    • Rapid tests
    • Strip readers (Lateral flow readers)
    • Elisa tests
    • Allergen-specific immunodiagnostic tests
    • Immunoassay analyzers
    • Other immunodiagnostic Animal Types
  • Hematology
    • Cartridges
    • Analyzers
  • Urinalysis
    • Clips & cartridges/panels
    • Urine Analyzers
    • Urine test strips
  • Molecular diagnostics
    • Polymerase chain reaction tests
    • Microarrays
    • Other molecular diagnostic Animal Types
  • Other Companion Animal Diagnostic Technologies

Global Companion Animal Diagnostics Market Size by Animal Type & CAGR (2024-2031)

  • Market Overview
  • Dogs
  • Cats
  • Horses
  • Other companion animals

Global Companion Animal Diagnostics Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Clinical Pathology
  • Bacteriology
  • Virology
  • Parasitology
  • Other Applications

Global Companion Animal Diagnostics Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Diagnostic Laboratories
  • Veterinary Hospitals & Clinics
  • Research Institutes & Universities
  • Home-care Settings

Global Companion Animal Diagnostics Market Size & CAGR (2024-2031)

  • North America (Technology, Animal Type, Application, End User)
    • US
    • Canada
  • Europe (Technology, Animal Type, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Technology, Animal Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Technology, Animal Type, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Technology, Animal Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Idexx Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerieux SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Indical Bioscience GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Idvet
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories, Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bionote, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Skyla Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Urit Medical Electronic Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nova Biomedical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fassisi GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Swissavans AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alvedia
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Megacor Veterinary Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biopanda Reagents Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anipoc Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ring Biotechnology Co Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!